FIELD: medicine.
SUBSTANCE: invention relates to ophthalmology and represents a method for assessing severity of retinoblastoma in children. According to the invention, determine in blood serum antibodies to early antigen of Epstein-Barr virus, and, in case of their presence, estimated the progress as severe.
EFFECT: invention implementation ensures higher effectiveness of therapy due to early determination of severity of retinoblastoma progress in children.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR VARIOUS FORMS OF PRIMARY INITIAL RETINOBLASTOMA IN CHILDREN | 2012 |
|
RU2479255C1 |
| METHOD OF THERAPEUTIC APPROACH SELECTION AT INITIAL STAGE OF RETINOBLASTOMA IN CHILDREN | 2018 |
|
RU2673860C1 |
| METHOD OF DIAGNOSING SMALL RETINOBLASTOMA IN CHILDREN | 2023 |
|
RU2799256C1 |
| METHOD FOR VISUAL FUNCTIONS STATE PREDICTION FOR CHILDREN WITH RETINOBLASTOMA AT BACKGROUND OF SYSTEMIC CHEMOTHERAPY | 2016 |
|
RU2624391C1 |
| METHOD OF TREATING NON-HODGEKIN ORBIT LYMPHOMAS | 2015 |
|
RU2612006C1 |
| METHOD OF ASSESSING EFFICIENCY OF COMBINED ORGAN-PRESERVING TREATMENT OF PRIMARY INITIAL RETINOBLASTOMA IN CHILDREN | 2012 |
|
RU2486859C1 |
| METHOD FOR EARLY DIAGNOSTICS OF OPTICAL NEUROPATHY AGAINST THE BACKGROUND OF SYSTEMATIC OR COMBINED CHEMOTHERAPY IN CHILDREN WITH RETINOBLASTOMA | 2020 |
|
RU2750153C1 |
| METHOD FOR LASER TREATMENT OF RESISTANT FORMS OF RETINOBLASTOMA IN CHILDREN | 2015 |
|
RU2600145C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE COURSE OF INITIAL CHOROID MELANOMA AFTER ORGAN-PRESERVING TREATMENT, BASED ON DETERMINATION OF LEVEL OF TRANSFORMING GROWTH FACTOR TGF-β2 | 2020 |
|
RU2733577C1 |
| METHOD OF DIAGNOSING INTRAOCULAR NEOPLASMS | 2008 |
|
RU2387378C1 |
